<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001142" GROUP_ID="PREG" ID="429199081020092228" MERGED_FROM="" MODIFIED="2015-09-07 14:24:58 +0100" MODIFIED_BY="Frances Kellie" NOTES="&lt;p&gt;Short title (no longer in use): Constipation in pregnancy&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2015-09-07 14:14:25 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0193" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2015-09-07 14:24:58 +0100" MODIFIED_BY="Frances Kellie">
<TITLE>Interventions for treating constipation in pregnancy</TITLE>
<CONTACT MODIFIED="2015-09-07 14:24:58 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="45181B7A82E26AA200DA2AF32BA60AA9" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Frances</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Kellie</LAST_NAME><POSITION>Managing Editor</POSITION><EMAIL_1>f.kellie@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7959570</PHONE_1><FAX_1>+44 151 7959598</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-09-07 14:24:58 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="7689" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>David</FIRST_NAME><LAST_NAME>Jewell</LAST_NAME><EMAIL_1>mdjewell99@gmail.com</EMAIL_1><EMAIL_2>david.jewell@bristol.ac.uk</EMAIL_2><ADDRESS><DEPARTMENT>Division of Primary Health Care</DEPARTMENT><ORGANISATION>University of Bristol</ORGANISATION><ADDRESS_1>Cotham House</ADDRESS_1><ADDRESS_2>Cotham Hill</ADDRESS_2><CITY>Bristol</CITY><ZIP>BS6 6JL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 117 9082901</PHONE_1><FAX_1>+44 117 9546677</FAX_1></ADDRESS></PERSON><PERSON ID="16064" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gavin</FIRST_NAME><LAST_NAME>Young</LAST_NAME><EMAIL_1>gavinlyoung@btinternet.com</EMAIL_1><ADDRESS><ORGANISATION>Temple Sowerby Medical Practice</ORGANISATION><ADDRESS_1>Linden Park</ADDRESS_1><ADDRESS_2>Temple Sowerby</ADDRESS_2><CITY>Penrith</CITY><ZIP>CA10 1RW</ZIP><REGION>Cumbria</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 176 8361232</PHONE_1><FAX_1>+44 176 8361980</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-09-11 09:41:50 +0100" MODIFIED_BY="Lixia Dou" NOTES="&lt;p&gt;Response to feedback added: 1/15/01&lt;/p&gt;&lt;p&gt;Reformatted: 8/11/99&lt;/p&gt;" NOTES_MODIFIED="2008-09-11 09:41:50 +0100" NOTES_MODIFIED_BY="Lixia Dou">
<UP_TO_DATE>
<DATE DAY="26" MONTH="2" YEAR="2001"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="26" MONTH="2" YEAR="2001"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2015-09-07 14:14:25 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-09-07 14:14:25 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="9" YEAR="2015"/>
<DESCRIPTION>
<P>Text has been added to <LINK TAG="PUBLIC_NOTES" TYPE="SECTION">Published notes</LINK> to explain that this review will not be updated and has been superseded by <LINK REF="REF-Rungsiprakarn-2015" TYPE="REFERENCE">Rungsiprakarn 2015</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-09-07 14:07:35 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-09-07 14:07:35 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-01-18 09:13:05 +0000" MODIFIED_BY="Denise Atherton">
<DATE DAY="11" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-30 10:56:20 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="26" MONTH="2" YEAR="2001"/>
<DESCRIPTION>
<P>Search updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-10-30 10:55:21 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="26" MONTH="2" YEAR="2001"/>
<DESCRIPTION>
<P>An additional study (<LINK REF="STD-Greenhalf-1973" TYPE="STUDY">Greenhalf 1973</LINK>) has been incorporated into this review and the text has been altered in response to a comment from Andrew Herxheimer.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2008-10-30 10:55:06 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="1" YEAR="2001"/>
<DESCRIPTION>
<P>Response to feedback added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-09-07 14:12:20 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-09-11 09:46:37 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-11 09:46:32 +0100" MODIFIED_BY="[Empty name]">Interventions for treating constipation in pregnancy</TITLE>
<SUMMARY_BODY MODIFIED="2008-09-11 09:46:37 +0100" MODIFIED_BY="[Empty name]">
<P>Mild laxatives help relieve constipation in pregnancy.</P>
<P>Constipation is a common problem in late pregnancy. The time taken for food to get through the gut to the bowel is increased in the second and third trimester and may be caused by an increase in the hormone, progesterone. Adding more fibre to the diet increases the frequency of defecation (bowel movement) and leads to softer stools. The review of trials found that laxatives which stimulate the bowel are more effective than those that add bulk but may cause more adverse effects such as diarrhoea and abdominal pain. Fibre supplements are effective and appear to have no adverse effects.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Constipation is a common problem in late pregnancy. Circulating progesterone may be the cause of slower gastrointestinal movement in mid and late pregnancy. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>The objective of this review was to assess the effects of different methods for treating constipation in pregnancy.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the Cochrane Pregnancy and Childbirth Group trials register, the Cochrane Controlled Trials Register and MEDLINE. Date of last search: January 2001.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised trials of any treatment for constipation in pregnancy.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Trial quality assessments and data extraction were done independently by two reviewers.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Two suitable trials were identified. Fibre supplements increased the frequency of defecation (odds ratio 0.18, 95% confidence interval 0.05 to 0.67), and lead to softer stools. Stimulant laxatives are more effective than bulk-forming laxatives (odds ratio 0.30, 95% confidence interval 0.14 to 0.61), but may cause more side effects. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Dietary supplements of fibre in the form of bran or wheat fibre are likely to help women experiencing constipation in pregnancy. If the problem fails to resolve, stimulant laxatives are likely to prove more effective. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-09-11 09:47:28 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>The prevalence of constipation in pregnancy is reported to be 11-38%. It appears to be a problem of gastrointestinal motility, since there is an increase in gut transit time in the second and third trimester compared with both the first trimester and the postpartum period. As with heartburn of pregnancy, the likely cause is the rising level of circulating progesterone (<LINK REF="REF-West-1992" TYPE="REFERENCE">West 1992</LINK>).</P>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effectiveness of different methods for treating constipation in pregnancy.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-09-11 09:47:28 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All acceptably controlled trials evaluating treatments for constipation in pregnancy.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Pregnant women complaining of constipation, however defined, either spontaneously or in response to specific questioning.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Any interventions intended to increase the frequency or ease of defecation.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Changes in the frequency or ease of defecation.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-09-11 09:47:28 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2008-09-11 09:47:28 +0100" MODIFIED_BY="[Empty name]">
<P>This review has drawn on the search strategy for the Pregnancy and Childbirth Group as a whole. See Review Group's details for more information. In addition, MEDLINE and the Cochrane Controlled Trials Register were searched using the terms 'constipat*' and 'pregnan*'. Date of last search: January 2001.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Trials under consideration were evaluated for methodological quality and appropriateness for inclusion, without consideration of their results. Included trial data were processed as described in <LINK REF="REF-Clarke-2000" TYPE="REFERENCE">Clarke 2000</LINK>.</P>
<P>All studies were read by both reviewers, who made independent assessments of quality of allocation concealment and who extracted data independently. Disagreements were resolved by discussion.</P>
<P>In the two included trials the numbers in each treatment group were small and there were no significant differences between different treatments of the same type (corn-based biscuits compared with wheat bran in <LINK REF="STD-Anderson-1985" TYPE="STUDY">Anderson 1985</LINK>; senna compared with dioctyl sodium succinate and sterculia alone compared with sterculia and frangula in <LINK REF="STD-Greenhalf-1973" TYPE="STUDY">Greenhalf 1973</LINK>). For this reason the two groups in each case have been combined (fibre supplements in <LINK REF="STD-Anderson-1985" TYPE="STUDY">Anderson 1985</LINK>; stimulant laxatives and bulk-forming laxatives respectively in <LINK REF="STD-Greenhalf-1973" TYPE="STUDY">Greenhalf 1973</LINK>). </P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>Two trials were found that met the inclusion criteria and provided data that could be used in a meta-analysis. Two others have been excluded as their results were not usable. See tables of included and excluded studies.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>
<LINK REF="STD-Anderson-1985" TYPE="STUDY">Anderson 1985</LINK> was a trial of fibre supplements in 40 ambulant women. The control group was not given any placebo preparation, but the authors note the difficulty of providing a suitable preparation in such trials. The other trial compared two different stimulant laxatives with two different bulk-forming laxatives; there was no control group without laxatives (<LINK REF="STD-Greenhalf-1973" TYPE="STUDY">Greenhalf 1973</LINK>). It is of moderate quality: details are not given of the method of randomisation although it is stated that researchers were blind to the type of intervention. There is also inadequate information about numbers, with the paper reporting recruitment of 175 women but data only given for 140. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>There is clear evidence of the effectiveness of fibre supplements on the frequency of defecation (odds ratio (OR) 0.18, 95% confidence interval (CI) 0.05-0.67). Participants also reported a change to softer faeces. The finding is supported by <LINK REF="STD-Gregersen-1985" TYPE="STUDY">Gregersen 1985</LINK>, which reported a statistically significant improvement of frequency of defecation in women in the treated group compared with those in the control group. <LINK REF="STD-Browne-1957" TYPE="STUDY">Browne 1957</LINK> reported an increase in frequency in response to a single dose of 7.5 mg of senna (a small dose compared with current standard clinical practice), when compared with a placebo syrup. <LINK REF="STD-Greenhalf-1973" TYPE="STUDY">Greenhalf 1973</LINK> demonstrated that stimulant laxatives are more effective than bulk forming laxatives (OR 0.30, 95% CI 0.14 to 0.61). They are at the same time more likely to cause side effects of diarrhoea and abdominal pain. The acceptability is the same between the two groups, with effectiveness and side effects apparently balancing out in patients' reactions (<LINK REF="STD-Greenhalf-1973" TYPE="STUDY">Greenhalf 1973</LINK>).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>The findings of these two small trials and the excluded trials are consistent with what is known about laxatives in non-pregnant patients. Fibre supplements are effective, and raise no serious concerns about side effects to mother or fetus. Stimulant laxatives are more effective than bulk-forming laxatives but are more likely to cause side-effects that reduce their acceptability to patients. </P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Women complaining of constipation in pregnancy can be treated effectively with daily dietary supplements of fibre in the form of bran or wheat fibre. If these are ineffective, stimulant laxatives may be effective. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Besides the meagre data presented in this review about effectiveness, little is known about the long-term acceptability of daily fibre supplements to women, or about the relative effectiveness and acceptability of other common treatments for constipation such as increased exercise. There may therefore be an argument for carrying out further research to identify the most acceptable, as well as the most effective treatment.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>None.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Both reviewers read the papers and agreed extraction and interpretation of data. David Jewell was responsible for all data entry and writing the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2015-09-07 14:12:20 +0100" MODIFIED_BY="[Empty name]">
<P>This review will no longer be updated by the current review team and has been superseded by a new review on this topic, see <LINK REF="REF-Rungsiprakarn-2015" TYPE="REFERENCE">Rungsiprakarn 2015</LINK>.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-09-07 14:12:01 +0100" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1985" NAME="Anderson 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;[1539]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson AS, Whichelow MJ</AU>
<TI>Constipation during pregnancy: dietary fibre intake and the effect of fibre supplementation</TI>
<SO>Human Nutrition: Applied Nutrition</SO>
<YR>1985</YR>
<VL>39</VL>
<PG>202-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Greenhalf-1973" NAME="Greenhalf 1973" YEAR="1973">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Greenhalf JO, Leonard HSD</AU>
<TI>Laxatives in the treatment of constipation in pregnant and breast-feeding mothers</TI>
<SO>Practitioner</SO>
<YR>1973</YR>
<VL>210</VL>
<PG>259-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Browne-1957" NAME="Browne 1957" YEAR="1957">
<REFERENCE NOTES="&lt;p&gt;[109]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Browne JCM, Edmunds V, Fairbairn JW, Reid DD</AU>
<TI>Clinical and laboratory assessments of senna preparations</TI>
<SO>British Medical Journal</SO>
<YR>1957</YR>
<VL>23</VL>
<PG>436-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gregersen-1985" NAME="Gregersen 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;[153]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gregersen E</AU>
<TI>Constipation during pregnancy. Treatment with Dumovital fibre tablets [translation]</TI>
<SO>Ugeskrift for Laeger</SO>
<YR>1985</YR>
<VL>147</VL>
<PG>91-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-09-07 14:12:01 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-09-07 14:12:01 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Clarke-2000" MODIFIED="2008-09-11 09:50:32 +0100" MODIFIED_BY="[Empty name]" NAME="Clarke 2000" TYPE="OTHER">
<AU>Clarke M, Oxman AD, editors.</AU>
<TI>Cochrane Reviewers' Handbook 4.1 [updated June 2000]. In: Review Manager (RevMan) [Computer program]. Version 4.1 Oxford, England: The Cochrane Collaboration, 2000</TI>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rungsiprakarn-2015" MODIFIED="2015-09-07 14:12:01 +0100" MODIFIED_BY="[Empty name]" NAME="Rungsiprakarn 2015" TYPE="COCHRANE_REVIEW">
<AU>Rungsiprakarn P, Laopaiboon M, Sangkomkamhang US, Lumbiganon P, Pratt JJ</AU>
<TI>Interventions for treating constipation in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2015-09-07 14:11:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-09-07 14:11:52 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD011448.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-West-1992" NAME="West 1992" TYPE="JOURNAL_ARTICLE">
<AU>West L, Warren J, Cutts T</AU>
<TI>Diagnosis and management of irritable bowel syndrome, constipation, and diarrhoea in pregnancy</TI>
<SO>Gastroenterology Clinics of North America</SO>
<YR>1992</YR>
<VL>21</VL>
<NO>4</NO>
<PG>793-802</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-CDSR-2001" NAME="CDSR 2001" TYPE="COCHRANE_REVIEW">
<AU>Jewell DJ, Young G</AU>
<TI>Interventions for treating constipation in pregnancy (Cochrane Review)</TI>
<SO>The Cochrane Library</SO>
<YR>2001</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jewell-1995" NAME="Jewell 1995" TYPE="OTHER">
<AU>Jewell MD</AU>
<TI>Treatments for constipation in pregnancy. [revised 30 April 1993] In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</TI>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES>
<REFERENCE ID="REF-Amadeo-1990" NAME="Amadeo 1990" TYPE="JOURNAL_ARTICLE">
<AU>Amadeo A, Fatti F, Pellegrini V, Szijarto A</AU>
<TI>Controlled double blind study versus placebo of a formulation of glaucomannan and mineral salts in pregnant patients with constipation</TI>
<SO>Rassegna Internazionale di Clinica e Terapia</SO>
<YR>1990</YR>
<VL>70</VL>
<NO>19</NO>
<PG>881-90</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Anderson-1985">
<CHAR_METHODS>
<P>Women randomised into three groups, method of randomisation not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>40 women recruited from routine antenatal clinics in the third trimester of pregnancy. Women recruited in last trimester from antenatal clinics in Cambridge, UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Women in two intervention groups given 10gm dietary supplement per day, either in the form of corn-based biscuits (proprietary product 'Fibermed') or as 23g wheat bran. Control group given nothing (ie not a placebo group), all for two weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Increase in stool frequency over two weeks of treatment.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Energy and fibre intake were carefully monitored throughout the study. There were no differences in outcomes between the two treatment groups. This is unsurprising since the two treatments are different forms of fibre (ie the same type of laxative). For these reasons the two treatment groups have been combined in the meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Greenhalf-1973">
<CHAR_METHODS>
<P>Women randomised into four groups, method not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Women attending hospital antenatal clinic in UK. 175 women recorded as being entered, but data only available for 140 (35 in each group).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Groups given oral medication as follows:<BR/>1. Senna 14mg daily (Senokot).<BR/>2. Dioctyl sodium succinate 120mg and dihydroxyanthroquinone 100mg (Normax). <BR/>3. 10ml daily, <BR/>containing 60% sterculia and 8% frangula (Normacol standard).<BR/>4. 10ml daily, containing 60% sterculia (Normacol special).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure to correct constipation; poor acceptability of preparation; side effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>For the meta-analysis groups 1 and 2 have been combined as stimulant laxatives and groups 3 and 4 as bulk-forming laxatives.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Browne-1957">
<CHAR_REASON_FOR_EXCLUSION>
<P>Double-blind randomised controlled trial, studying pregnant women admitted to hospital. Trial of different preparations and doses of senna. At higher doses (equivalent to 7.5 mg daily) increase in frequency of defecation noted within 24 hours of dose. However, results only presented as means for each treatment group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gregersen-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomised double-blind controlled study of constipation treated with fibre tablets (Dumovital) or placebo. The paper reported an increase in frequency of defecation in the fibre tablet group. Data only presented as means for the whole group, and therefore impossible to know how many patients recovered in each group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Anderson-1985">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Greenhalf-1973">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Effect of additional dietary fibre</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.6730190638205225" CI_START="0.04916665249304999" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.1819068289868785" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.17197263385210546" LOG_CI_START="-1.3083293596025871" LOG_EFFECT_SIZE="-0.7401509967273463" METHOD="PETO" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.010674018117883132" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="27" TOTAL_2="13" WEIGHT="100.0" Z="2.5531934890409698">
<NAME>No increased frequency of defecation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="0.6730190638205225" CI_START="0.04916665249304999" EFFECT_SIZE="0.1819068289868785" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="-0.17197263385210546" LOG_CI_START="-1.3083293596025871" LOG_EFFECT_SIZE="-0.7401509967273463" ORDER="86272" O_E="-3.8249999999999993" SE="0.6675015657623451" STUDY_ID="STD-Anderson-1985" TOTAL_1="27" TOTAL_2="13" VAR="2.2443750000000002" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Comparison of stimulant laxatives with bulk-forming laxatives</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.6139293449471186" CI_START="0.14299934662100994" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.21188160746671414" LOG_CI_START="-0.8446659468673734" LOG_EFFECT_SIZE="-0.5282737771670437" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.001065958645770088" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.0" Z="3.272513280606846">
<NAME>Effect on constipation not resolved</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6139293449471186" CI_START="0.14299934662100994" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="35" LOG_CI_END="-0.21188160746671414" LOG_CI_START="-0.8446659468673734" LOG_EFFECT_SIZE="-0.5282737771670437" ORDER="86273" O_E="0.0" SE="0.3717006532969449" STUDY_ID="STD-Greenhalf-1973" TOTAL_1="70" TOTAL_2="70" VAR="0.13816137566137565" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7310373408198254" CI_START="0.4595343659344519" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8918918918918919" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.2383064362965887" LOG_CI_START="-0.33768200467480375" LOG_EFFECT_SIZE="-0.04968778418910752" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.7352474798321632" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.0" Z="0.3381535480747134">
<NAME>Treatment not acceptable to women</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7310373408198254" CI_START="0.4595343659344519" EFFECT_SIZE="0.8918918918918919" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.2383064362965887" LOG_CI_START="-0.33768200467480375" LOG_EFFECT_SIZE="-0.04968778418910752" ORDER="86274" O_E="0.0" SE="0.3383384614153621" STUDY_ID="STD-Greenhalf-1973" TOTAL_1="70" TOTAL_2="70" VAR="0.11447291447291447" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.817301970443859" CI_END="3.406102838607024" CI_START="1.2715113639389664" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="2.081081081081081" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="32" I2="70.66288087764163" I2_Q="70.61531832744055" ID="CMP-002.03" LOG_CI_END="0.5322577562411797" LOG_CI_START="0.10432024596979414" LOG_EFFECT_SIZE="0.3182890011054869" METHOD="MH" NO="3" P_CHI2="0.0330859330808142" P_Q="0.033268979052675896" P_Z="0.003550708518530117" Q="6.8062673684421" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="210" TOTAL_2="210" WEIGHT="100.0" Z="2.91554240452708">
<NAME>Effect on side effects</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.111798945288737" CI_START="1.3898501404791301" DF="0" EFFECT_SIZE="2.9145299145299144" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="15" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.786169059182188" LOG_CI_START="0.14296797531048408" LOG_EFFECT_SIZE="0.4645685172463361" NO="1" P_CHI2="1.0" P_Z="0.004636374727402991" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="37.64478764478765" Z="2.8312687431217514">
<NAME>Side effects: abdominal pain</NAME>
<DICH_DATA CI_END="6.111798945288737" CI_START="1.38985014047913" EFFECT_SIZE="2.9145299145299144" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="15" LOG_CI_END="0.786169059182188" LOG_CI_START="0.142967975310484" LOG_EFFECT_SIZE="0.4645685172463361" ORDER="86275" O_E="0.0" SE="0.3778195005629534" STUDY_ID="STD-Greenhalf-1973" TOTAL_1="70" TOTAL_2="70" VAR="0.14274757500563953" WEIGHT="37.64478764478765"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.910399063913458" CI_START="1.2210064346960667" DF="0" EFFECT_SIZE="2.904761904761904" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="9" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.8395031278736526" LOG_CI_START="0.08671795268004288" LOG_EFFECT_SIZE="0.46311054027684767" NO="2" P_CHI2="1.0" P_Z="0.015885980651473414" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="28.37837837837838" Z="2.4115245881935983">
<NAME>Side effects: diarrhoea</NAME>
<DICH_DATA CI_END="6.910399063913458" CI_START="1.2210064346960667" EFFECT_SIZE="2.9047619047619047" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="9" LOG_CI_END="0.8395031278736526" LOG_CI_START="0.08671795268004288" LOG_EFFECT_SIZE="0.4631105402768477" ORDER="86276" O_E="0.0" SE="0.4421897382554413" STUDY_ID="STD-Greenhalf-1973" TOTAL_1="70" TOTAL_2="70" VAR="0.19553176461841565" WEIGHT="28.37837837837838"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6382297764999656" CI_START="0.13466684985659014" DF="0" EFFECT_SIZE="0.4696969696969697" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" ID="CMP-002.03.03" LOG_CI_END="0.21437481541427053" LOG_CI_START="-0.8707392988294624" LOG_EFFECT_SIZE="-0.32818224170759597" NO="3" P_CHI2="1.0" P_Z="0.2358023693823964" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="33.97683397683398" Z="1.1855442034514516">
<NAME>Side effects: nausea</NAME>
<DICH_DATA CI_END="1.6382297764999654" CI_START="0.13466684985659014" EFFECT_SIZE="0.4696969696969697" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.21437481541427048" LOG_CI_START="-0.8707392988294624" LOG_EFFECT_SIZE="-0.32818224170759597" ORDER="86277" O_E="0.0" SE="0.637401402108263" STUDY_ID="STD-Greenhalf-1973" TOTAL_1="70" TOTAL_2="70" VAR="0.40628054740957964" WEIGHT="33.97683397683398"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK>
<FEEDBACK_ITEM ID="FBK-01" NO="1">
<TITLE>Herxheimer, September 1998</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY>
<P>Summary of analyses:<BR/>Anderson 1985 was a three arm study, and the two groups given dietary fibre are combined within the review. Lumping in this way should be justified, and the groups reported separately as well as together.</P>
<P>Results:<BR/>If there is any information about acceptability and patient preferences for any of the groups this should also be presented. Absolute numbers of defecations/day would also be useful information.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY>
<P>Summary of analyses:<BR/>In Anderson 1985 the active ingredient for the two dietary fibre groups was the same, although the formulation was different. As formulation alone would be unlikely to influence the effect, lumping is justified. It also gives a more useful result. Data on similar laxatives from Greenhalf 1973 have also been lumped. Text in the results section and table of included references make this explicit. </P>
<P>Results:<BR/>None of these papers report any data on numbers of defecations. Data on acceptability was reported in Greenhalf 1973 and has been included in the review.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>Summary of comments from Andrew Herxheimer, September 1998.<BR/>Summary of response from David Jewell, January 2001.</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>